(lp0
S"SUNESIS PHARMACEUTICALS, INC.  Files An 8-K Results of Operations ... Market Exclusive - Mar 9, 2017 Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers.Sunesis Pharmaceuticals'  CEO Daniel Swisher on Q4 2016 Results ... - Seeking Alpha"
p1
aS'Sunesis Pharmaceuticals, Inc.  Cut to Hold at Zacks Investment Research The Cerbat Gem - 13 hours ago Zacks Investment Research downgraded shares of Sunesis Pharmaceuticals, Inc.  from a buy rating to a hold rating in a research report released on Wednesday morning.'
p2
aS'Sunesis Pharmaceuticals updates on SNS-062 and Vosaroxin programs Seeking Alpha - Jan 23, 2017 Sunesis Pharmaceuticals  announces clinical and regulatory updates to its two lead programs, SNS-062, a second-generation reversible and non-covalent BTK inhibitor, and vosaroxin, an anti-cancer quinolone derivative currently under review ...'
p3
aS'Sunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results and ... GlobeNewswire  - Jul 29, 2016 SOUTH SAN FRANCISCO, Calif., July 29, 2016  -- Sunesis Pharmaceuticals, Inc.  today reported financial results for the second quarter ended June 30, 2016.Cowen Comments on Sunesis Pharmaceuticals, Inc.  Following 2Q:16 Update - Smarter Analyst'
p4
aS"Sunesis Pharmaceuticals Announces Poster Presentation on Preliminary Results ... GlobeNewswire  - Sep 1, 2016 SOUTH SAN FRANCISCO, Calif., Sept. 01, 2016  -- Sunesis Pharmaceuticals, Inc.  today announced that a poster detailing preliminary results from the Company's Phase 1A study in healthy volunteers evaluating oral&nbsp;..."
p5
aS'Crunching the Numbers for Sunesis Pharmaceuticals Inc  Davidson Register - 13 hours ago Investors and Traders using technical analysis to study stocks may be looking at the ATR or Average True Range. Presently, Sunesis Pharmaceuticals Inc  has a 14-day ATR of 0.19. The Average True Range is an investor tool used to gauge stock&nbsp;...'
p6
aS'Sunesis Pharmaceuticals Announces 1-for-6 Reverse Stock Split GlobeNewswire  - Sep 7, 2016 SOUTH SAN FRANCISCO, Calif., Sept. 07, 2016  -- Sunesis Pharmaceuticals, Inc.  today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-6&nbsp;...'
p7
aS'Does Sunesis Pharmaceuticals, Inc.  Have Sufficient Cash To ... Scibility Media - Aug 1, 2016 Sunesis Pharmaceuticals, Inc.  continues to lose money as its latest financial results for 2Q2016 and 1H2016 show.'
p8
aS'Sunesis Pharmaceuticals Inc Risk Points versus Health Care CML News - Mar 7, 2017 This is a scatter plot analysis of the critical risk points from the option market for Sunesis Pharmaceuticals Inc  compared to its own past and the Health Care ETF.'
p9
aS'Sunesis Pharmaceuticals Inc.: Sunesis to Host Conference Call on March 9th to ... The Wall Street Transcript - Mar 2, 2017 SOUTH SAN FRANCISCO, Calif., March 02, 2017  -- Sunesis Pharmaceuticals, Inc.  today announced that it will host a conference call on Thursday, March 9, 2017 at 11:00 a.m.Sunesis Pharmaceuticals, Inc.  Valuation According To Analysts - UK Market News'
p10
a.